Showing 17,441 - 17,460 results of 25,933 for search '(( 5 ((nn decrease) OR (mean decrease)) ) OR ( 50 ((c decrease) OR (a decrease)) ))', query time: 0.68s Refine Results
  1. 17441
  2. 17442
  3. 17443
  4. 17444
  5. 17445
  6. 17446
  7. 17447
  8. 17448
  9. 17449

    Table1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppress... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  10. 17450

    DataSheet3_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  11. 17451

    DataSheet4_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  12. 17452

    DataSheet1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  13. 17453

    DataSheet6_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  14. 17454

    DataSheet5_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  15. 17455

    DataSheet2_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  16. 17456

    DataSheet7_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  17. 17457

    <i>Sox2</i> and <i>Fgf20</i> interact during cochlea development—quantitative analysis. by Lu M. Yang (6919364)

    Published 2019
    “…(B-E) Quantification of (B) cochlear duct length, (C) total inner hair cells (IHCs) and IHCs per 100 μm of the cochlear duct, (D) total outer hair cells (OHCs) and OHCs per 100 μm, and (E) total supporting cells (SCs) and SCs per 100 μm at P0 in <i>Fgf20</i><sup><i>+/+</i></sup>;<i>Sox2</i><sup><i>+/+</i></sup>, <i>Fgf20</i><sup><i>+/+</i></sup>;<i>Sox2</i><sup><i>Ysb/+</i></sup>, <i>Fgf20</i><sup><i>+/-</i></sup>;<i>Sox2</i><sup><i>+/+</i></sup>, <i>Fgf20</i><sup><i>+/-</i></sup>;<i>Sox2</i><sup><i>Ysb/+</i></sup>, <i>Fgf20</i><sup><i>+/+</i></sup>;<i>Sox2</i><sup><i>Ysb/Ysb</i></sup>, <i>Fgf20</i><sup><i>+/-</i></sup>;<i>Sox2</i><sup><i>Ysb/Ysb</i></sup>, <i>Fgf20</i><sup><i>-/-</i></sup>;<i>Sox2</i><sup><i>+/+</i></sup>, <i>Fgf20</i><sup><i>-/-</i></sup>;<i>Sox2</i><sup><i>Ysb/+</i></sup>, and <i>Fgf20</i><sup><i>-/-</i></sup>;<i>Sox2</i><sup><i>Ysb/Ysb</i></sup> cochleae. Error bars, mean ± SD. n = (B) 5, 6, 5, 6, 6, 6, 4, 10, 10; (C, D) 5, 5, 5, 4, 4, 4, 4, 5, 6; (E) 4, 5, 3, 3, 3, 3, 3, 5, 5. …”
  18. 17458

    VR Study: Relevant Data by Authors kept anonymous for the purpose of blind peer review (19263752)

    Published 2024
    “…We sought to explore the predictors of the social experience of virtual reality presentations of a Western art music concert.</p> <p>We used a pragmatic, mixed methods approach to collect the data. 50 participants were presented a monoscopic 360° VR recording of a string quintet concert. …”
  19. 17459

    Open question responses VR by Authors kept anonymous for the purpose of blind peer review (19263752)

    Published 2024
    “…We sought to explore the predictors of the social experience of virtual reality presentations of a Western art music concert.</p> <p>We used a pragmatic, mixed methods approach to collect the data. 50 participants were presented a monoscopic 360° VR recording of a string quintet concert. …”
  20. 17460